Published in Invest Ophthalmol Vis Sci on July 01, 1987
Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol (1998) 1.95
Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol (1995) 1.43
Involvement of Müller glial cells in epiretinal membrane formation. Graefes Arch Clin Exp Ophthalmol (2009) 1.05
Hyaluronic acid hydrogel immobilized with RGD peptides for brain tissue engineering. J Mater Sci Mater Med (2006) 0.93
ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res (1996) 5.97
Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology (1985) 3.83
A nondenaturing zwitterionic detergent for membrane biochemistry: design and synthesis. Proc Natl Acad Sci U S A (1980) 2.51
Solubilization of functional membrane proteins. Methods Enzymol (1984) 2.41
Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol (1990) 2.13
Comparison of recombinant human PTH(1-34) (LY333334) with a C-terminally substituted analog of human PTH-related protein(1-34) (RS-66271): In vitro activity and in vivo pharmacological effects in rats. J Bone Miner Res (1999) 2.05
Solubilization of active opiate receptors. Proc Natl Acad Sci U S A (1980) 1.98
Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest (1985) 1.79
Beta-galactosidase histochemistry and telomere loss in senescent retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (1999) 1.67
Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci (1999) 1.67
Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol (1991) 1.52
Senescence-associated beta-galactosidase histochemistry for the primate eye. Invest Ophthalmol Vis Sci (1999) 1.32
Use of the ARPE-19 cell line as a model of RPE polarity: basolateral secretion of FGF5. Invest Ophthalmol Vis Sci (1998) 1.32
Solubilization of native membrane proteins. Methods Enzymol (1990) 1.27
Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochem Biophys Res Commun (1988) 1.19
Sulfobetaine derivatives of bile acids: nondenaturing surfactants for membrane biochemistry. Anal Biochem (1983) 1.15
Electrofocusing of integral membrane proteins in mixtures of zwitterionic and nonionic detergents. Anal Biochem (1979) 1.15
Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media. Exp Eye Res (1989) 1.14
Genetic mechanisms controlling the induction of polysubstrate monooxygenase (P-450) activities. Annu Rev Pharmacol Toxicol (1981) 1.13
Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch Ophthalmol (1991) 1.09
Comparison of photocoagulation with the argon, krypton, and diode laser indirect ophthalmoscopes in rabbit eyes. Ophthalmology (1992) 1.06
The Ah locus, a multigene family necessary for survival in a chemically adverse environment: comparison with the immune system. Adv Genet (1982) 1.05
The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells. Exp Eye Res (1998) 1.05
Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in Bruch's membrane of the aging eye. Mol Vis (1999) 1.04
Localization of basic fibroblast growth factor to the developing capillaries of the bovine retina. J Cell Physiol (1989) 1.01
Downregulation of differentiation specific gene expression by oxidative stress in ARPE-19 cells. Invest Ophthalmol Vis Sci (2001) 1.01
Angiogenic factors in human proliferative sickle cell retinopathy. Br J Ophthalmol (1999) 1.00
Role of IL-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide. J Eukaryot Microbiol (1995) 0.99
The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans. J Clin Immunol (1985) 0.98
The expression of native and cultured human retinal pigment epithelial cells grown in different culture conditions. Br J Ophthalmol (2005) 0.98
Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture. Invest Ophthalmol Vis Sci (1990) 0.94
Oxidative stress--induced single-strand breaks in chromosomal telomeres of human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci (2001) 0.94
Subcellular localization of bFGF in human retinal pigment epithelium in vitro. Exp Eye Res (1992) 0.93
Purification and immunochemical characterization of a low-pI form of UDP glucuronosyltransferase from mouse liver. Arch Biochem Biophys (1984) 0.92
Retinal glial cell proliferation and ion channels: a possible link. Invest Ophthalmol Vis Sci (1989) 0.92
PINP: a serum biomarker of bone formation in the rat. Bone (2006) 0.92
Doxorubicin-induced impairment of wound healing in rats. J Natl Cancer Inst (1986) 0.91
Fibrinolytic-assisted removal of experimental subretinal hemorrhage within seven days reduces outer retinal degeneration. Ophthalmology (1994) 0.91
The design and synthesis of detergents for membrane biochemistry. Methods Enzymol (1986) 0.91
Coexpression of FGF-5 and bFGF by the retinal pigment epithelium in vitro. Exp Eye Res (1992) 0.90
Induction of an aging mRNA retinal pigment epithelial cell phenotype by matrix-containing advanced glycation end products in vitro. Invest Ophthalmol Vis Sci (2001) 0.89
Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injection. Clin Immunol Immunopathol (1990) 0.89
A new class of nonionic detergents with a gluconamide polar group. Anal Biochem (1983) 0.88
The use of hyperoxia to induce chronic mild oxidative stress in RPE cells in vitro. Mol Vis (2001) 0.87
Ultramicrosurgical removal of subretinal hemorrhage in cats. Am J Ophthalmol (1992) 0.86
Identification of a PDGF-like mitoattractant produced by NIH/3T3 cells after transformation with SV40. J Cell Physiol (1985) 0.86
Intra-articular administration of interleukin-1 causes prolonged suppression of cartilage proteoglycan synthesis in rats. Matrix (1992) 0.85
Anisotropic conduction and functional dissociation of ischemic tissue during reentrant ventricular tachycardia in canine myocardial infarction. Circulation (1988) 0.85
Blood pressure determinations during medical examinations: how many? Can J Public Health (1975) 0.85
Removal of detergents from membrane proteins. Methods Enzymol (1990) 0.84
Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone. J Cell Biochem (1998) 0.84
Interleukin-1-induced suppression of type II collagen gene transcription involves DNA regulatory elements. Exp Cell Res (1990) 0.84
An optimized protocol for first strand cDNA synthesis from laser capture microdissected tissue. Lab Invest (2001) 0.84
Increasing cell density down-regulates the expression of acidic FGF by human RPE cells in vitro. Curr Eye Res (1993) 0.83
Induction of microsomal dimethylnitrosamine demethylase by pyrazole. Biochem Pharmacol (1982) 0.83
Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat. Arch Ophthalmol (1991) 0.83
Chemotaxis of rat brain astrocytes to platelet derived growth factor. Brain Res (1985) 0.83
Passive role of articular chondrocytes in quinolone-induced arthropathy in guinea pigs. Toxicol Pathol (1990) 0.83
Induction of interleukin-1 receptors on chondrocytes by fibroblast growth factor: a possible mechanism for modulation of interleukin-1 activity. J Cell Physiol (1989) 0.83
Density-dependent expression of FGF-2 in response to oxidative stress in RPE cells in vitro. Curr Eye Res (2001) 0.83
The mRNA phenotype of a human RPE cell line at replicative senescence. Mol Vis (1999) 0.83
Degradative and repair responses of cartilage to cytokines and growth factors occur via distinct pathways. Agents Actions Suppl (1993) 0.82
Cell density regulates differential production of bFGF transcripts. Growth Factors (1993) 0.82
Distribution of FGF-5 in the rhesus macaque retina. Invest Ophthalmol Vis Sci (1994) 0.81
Differential regulation of metalloprotease steady-state mRNA levels by IL-1 and FGF in rabbit articular chondrocytes. FEBS Lett (1992) 0.81
Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro. Bone (1997) 0.81
Osteonectin/SPARC is a product of articular chondrocytes/cartilage and is regulated by cytokines and growth factors. Biochim Biophys Acta (1994) 0.81
Intramolecular determination of primary kinetic isotope effects in hydroxylations catalyzed by cytochrome P-450. Biochem Biophys Res Commun (1976) 0.80
The 9E3 protein: immunolocalization in vivo and evidence for multiple forms in culture. J Cell Sci (1992) 0.80
Primary culture of human retinal glia. Invest Ophthalmol Vis Sci (1991) 0.80
Differentiation-dependent production of a platelet-derived growth factor-like mitoattractant by endoderm cells derived from embryonal carcinoma cells. J Cell Physiol (1988) 0.80
Apolipoprotein E in the subretinal fluid of rhegmatogenous and exudative retinal detachments. Retina (1997) 0.79
Induction of telomere shortening and replicative senescence by cryopreservation. Biochem Biophys Res Commun (2001) 0.79
Expression of FGF5 in choroidal neovascular membranes associated with ARMD. Curr Eye Res (1997) 0.79
Age and topographic variation of insulin-like growth factor-binding protein 2 in the human rpe. Invest Ophthalmol Vis Sci (2001) 0.79
Expression of the MAS proto-oncogene in the retinal pigment epithelium of the rhesus macaque. Curr Eye Res (1994) 0.78
Immunohistochemical localization of basic fibroblast growth factor in mature and developing retinas of normal and RCS rats. Curr Eye Res (1992) 0.78
Modulation of PDGF mediated osteoblast chemotaxis by leukemia inhibitory factor (LIF). J Cell Physiol (1996) 0.78
Wound healing in sarcoma-bearing rats: tumor effects on cutaneous and deep wounds. J Surg Oncol (1987) 0.77
Relation between the minimum RR interval during atrial fibrillation and the functional refractory period of the AV junction. Cardiovasc Res (1974) 0.77
Active site models of horseradish peroxidase compound I and a cytochrome P-450 analogue: electronic structure and electric field gradients. J Am Chem Soc (1977) 0.77
Cellular adhesion regulates bFGF gene expression in human retinal pigment epithelial cells. Exp Eye Res (1994) 0.77
Identification of a novel chemical series that blocks interleukin-1-stimulated metalloprotease activity in chondrocytes. J Pharmacol Exp Ther (1995) 0.77
Intramolecular determination of substituent effects in hydroxylations catalyzed by cytochrome P-450. Mol Pharmacol (1977) 0.77
Detection of c-sis proto-oncogene transcripts by direct enzyme-labeled cDNA probes and in situ hybridization. In Vitro Cell Dev Biol (1992) 0.76
Expression and splicing of FGF receptor mRNAs during APRE-19 cell differentiation in vitro. Invest Ophthalmol Vis Sci (2000) 0.76
Developmental expression of bFGF in the bovine retina. Invest Ophthalmol Vis Sci (1993) 0.76
Trace element status and free radical defense in elderly rhesus macaques (Macaca mulatta) with macular drusen. Proc Soc Exp Biol Med (1995) 0.76
Expression of a recombinant human RGR opsin in Lentivirus-transduced cultured cells. Mol Vis (2000) 0.76
Fibrinolysis of experimental subretinal haemorrhage without removal using tissue plasminogen activator. Br J Ophthalmol (1996) 0.75
Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes. Am J Ophthalmol (1997) 0.75
GTP stabilization of adenylate cyclase activated and ADP-ribosylated by choleragen. Biochem Biophys Res Commun (1981) 0.75
The electronic structure of chromyl chloride: a functional model for cytochrome P-450. J Am Chem Soc (1977) 0.75
Effects of re-use on the physical characteristics of angiographic catheters. J Med Eng Technol (1991) 0.75
The effects of ouabain on atrioventricular junctional automaticity and conductivity studied in the dog. Can J Physiol Pharmacol (1974) 0.75
[The transvenous temporary pacemaker]. Nurs Que (1990) 0.75
[Analysis of the drug prescription profile and lab profile by computerized codification of the hospital dossier]. Union Med Can (1973) 0.75
Asymmetric septal hypertrophy (ASH) and its obstructive form, idiopathic hypertrophic subaortic stenosis (IHSS), in pediatrics. J Am Osteopath Assoc (1980) 0.75